A recent industry analysis report by Future Market Insights anticipated that the global branched stent grafts market would be valued US$ 335.8 million in 2021.The market is expected to develop at a compound annual growth rate of 8.5% between 2022 and 2032, reaching a valuation of US$ 814 million by that time.The chimney application is anticipated to provide the highest revenue from the market, expanding at a compound annual growth rate (CAGR) of 9.3% between 2022 and 2032.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16087
FMI, in its upcoming business report, elaborates the historical and current scenario of the global Branched Stent Graft market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.
Crucial information and forecast statistics covered in the Branched Stent Graft market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.
COVID-19 Impact Analysis on Branched Stent Graft Market
The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Branched Stent Graft market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Branched Stent Graft market.
Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.
The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Branched Stent Graft market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.
Branched Stent Graft Market: Segmentation
Valuable information covered in the FMI’s Branched Stent Graft market report has been segregated into key segments and sub-segments.
Application Outlook:
- FEVAR
- Chimney
- Other EVARs
Type Outlook:
- Iliac Stent
- Other Types
Branched Stent Graft Market: Competition Analysis
The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Branched Stent Graft market. Competitive information detailed in the Branched Stent Graft market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Branched Stent Graft market report.
Key players covered in the report include:
Medtronic, Biotronik, Alvimedica, Endocor GmbH, Eucatech AG, Merit Medical Systems, Abbott, Cook Medical, Cardinal Health, Boston Scientific Corp., and Terumo Corp.
Important Questions Answered in the Branched Stent Graft Market Report
- Which end user remains the top revenue contributor in different regional markets?
- At what rate has the global Branched Stent Graft market been expanding during the forecast period?
- How will the global Branched Stent Graft market look like by the end of the forecast period?
- What innovative strategies are adopted by Branched Stent Graft market players to stay ahead of the pack?
- What are the restraints affecting the growth of the global Branched Stent Graft market?
Unleash Potential: Craft Your Customized Report Now:
https://www.futuremarketinsights.com/customization-available/rep-gb-16087
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
